| Patent application number | Description | Published |
|---|
| 20090200382 | Combi-Card and Method for Making the Same - The present invention relates to a combi-card which can be used in a contact-type or noncontact-type fashion and a method for manufacturing the same. More particularly, this invention relates to a combi-card and a method for making the same, in which an inlay layer on which an antenna terminal made of a coil or conductive fiber is formed and a COB (chip on board) on which ACF (anisotropic conductor film) is applied, are pre-treated by a heating head and the like, the COB is attached to an antenna coil insertion layer, and an upper printing sheet with a protection film, and a lower printing sheet with a protection film, which are cut out to be suitable for the COB shape, are stacked to construct a combi-card. | 08-13-2009 |
| 20100320270 | COMBI CARD AND COMMUNICATION SYSTEM USING THEREOF - Provided is a combi-card, i.e. a combination type IC card, which can be used in either contact and non-contact manner, and a communication system using the same, and the combi-card is provided with a transponder chip module formed with a RF antenna and attached in a recess region of a card body and is characterized by the use of the RF antenna of the transponder chip alone as a transmitting and receiving antenna. | 12-23-2010 |
| Patent application number | Description | Published |
|---|
| 20100063286 | PIPERAZINYL-PROPYL-PYRAZOLE DERIVATIVES AS DOPAMINE D4 RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder. | 03-11-2010 |
| 20100184781 | FXA INHIBITORS WITH CYCLIC AMIDINES AS P4 SUBUNIT, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS AND DERIVATIVES THEREOF - The present invention relates to novel oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa. | 07-22-2010 |
| 20110112083 | FXA INHIBITORS WITH CYCLIC AMIDOXIME OR CYCLIC AMIDRAZONE AS P4 SUBUNIT, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS AND DERIVATIVES THEREOF - The present invention relates to novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group, pharmaceutically acceptable salts thereof, methods for preparing the same and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group or the pharmaceutically acceptable salts thereof can be effectively used for the treatment of thromboembolism and tumor as an anticoagulant based on the inhibition of factor Xa. | 05-12-2011 |
| 20110178293 | Novel Oxazolidinone Derivatives with Cyclic Amidoxime or Cyclic Amidrazone and Pharmaceutical Compositions Thereof - Disclosed is a novel oxazolidinone derivative, particularly a novel oxazolidinone compound with a cyclic amidoxime or cyclic amidrazone group. Also disclosed is a pharmaceutical antibiotic composition including a novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof as an effective ingredient. Because the novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof exhibits a wide antibacterial spectrum against resistant bacteria, a low toxicity, and a strong antibacterial activity against Gram-positive and Gram-negative bacteria, it can be usefully used as an antibiotic. | 07-21-2011 |
| Patent application number | Description | Published |
|---|
| 20100019888 | APPARATUS AND METHOD FOR PROVIDING URL, MOBILE STATION, AND METHOD FOR ACCESSING INTERNET BY USING THE PROVIDED URL - The present invention relates to a URL providing apparatus and a method thereof, and a mobile station that accesses the Internet by using the provided URL, and an Internet access method thereof. The mobile station attaches an RF-ID tag that stores an RF-ID tag value corresponding to identification information of the mobile station thereto, and thus when a user brings the mobile station into an interrogation range of an RF-ID reader included in the URL providing apparatus, the URL providing apparatus receives the corresponding RF-ID tag value from the RF-ID reader. When the URL providing apparatus acquires an IP address of the mobile station by using the received RF-ID tag value and provides a URL to the mobile station by using the acquired IP address, the mobile station automatically accesses the Internet by using the URL. Such an Internet access method can minimize additional cost of the mobile station and simplify an Internet access process to a specific URL. | 01-28-2010 |
| 20100265828 | COMMUNICATION AND METHOD - A communication method according to the present invention includes receiving MAP in formation, acquiring an initial scheduled frame number and a current frame number from the MAP information, calculating the difference between the initial scheduled frame number and the current frame number, comparing the difference between the initial scheduled frame number and the current frame number with a reference value and setting a scheduled frame number, and performing transmission or reception in the scheduled frame. Therefore, even though a MAP loss occurs, the mobile station can receive only downlink data effective in downlink, thereby reducing power consumption for unnecessary reception, and can exactly perform transmission in a frame in which it should transmit in uplink. | 10-21-2010 |
| 20100290401 | METHOD OF TRANSMITTING SIGNAL - A method of transmitting a signal according to the present invention includes: receiving a signal that is encoded with a predetermined code rate and that is modulated by a first modulation method from a base station; creating a signal that is obtained by demodulating the signal that is modulated by the first modulation method using a method corresponding to the first modulation method; creating a signal that is obtained by modulating the demodulated signal using a second modulation method while maintaining the predetermined code rate; and transmitting the signal that is modulated by the second modulation to a mobile station. | 11-18-2010 |
| Patent application number | Description | Published |
|---|
| 20100113720 | METHOD FOR PREPARING ELASTOMERIC COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS - Provided is a process for preparing copolymers of ethylene with α-olefin. More specifically, provided are transition metal compound being useful as catalyst for preparing those copolymers, a catalyst composition comprising the same, and a process for preparing elastic copolymers of ethylene with α-olefin, having the density of not more than 0.910, which can be adopted to a wide variety of applications including film, electric wires, and hot-melt adhesives. The catalyst composition is a catalytic system which comprises transition metal catalyst comprising a cyclopentadiene derivative and at least one anionic ligand(s) of aryloxy group with an aryl derivative at ortho-position, and boron or aluminum compound as an activator. Provided is a process for copolymerizing ethylene with α-olefin to produce copolymer having narrow molecular weight distribution and uniform density distribution with the density of not more than 0.910, with high activity and excellent reactivity on higher α-olefin. | 05-06-2010 |
| 20100113729 | ETHYLENE COPOLYMER WITH IMPROVED IMPACT RESISTANCE - Provided are ethylene copolymers with excellent impact resistance. More specifically, provided are ethylene copolymers satisfying certain correlation between the falling dart impact strength (F) or high rate impact resistant breakage energy (E) and Vicat softening point. The ethylene copolymers with improved impact properties are applicable to film, injection, compound, sheet, roto, pipe or blow molding. | 05-06-2010 |
| 20100120981 | ETHYLENE COPOLYMER AND A METHOD OF PREPARING THE SAME - Provided are ethylene copolymers and a process for preparing the same. More specifically, provided are ethylene copolymers exhibiting excellent processibility and physical properties due to its multimodal molecular weight distribution index, through a multi-stage process by using reactors connected in series or in parallel in the presence of catalyst composition containing transition metal catalyst, and a process for preparing the same. | 05-13-2010 |
| 20110282011 | METHOD FOR PREPARING ELASTOMERIC COPOLYMERS OF ETHYLENE AND a-OLEFINS - Provided is a process for preparing copolymers of ethylene with α-olefin. More specifically, provided are transition metal compound being useful as catalyst for preparing those copolymers, a catalyst composition comprising the same, and a process for preparing elastic copolymers of ethylene with α-olefin, having the density of not more than 0.910, which can be adopted to a wide variety of applications including film, electric wires, and hot-melt adhesives. The catalyst composition is a catalytic system which comprises transition metal catalyst comprising a cyclopentadiene derivative and at least one anionic ligand(s) of aryloxy group with an aryl derivative at ortho-position, and boron or aluminum compound as an activator. Provided is a process for copolymerizing ethylene with α-olefin to produce copolymer having narrow molecular weight distribution and uniform density distribution with the density of not more than 0.910, with high activity and excellent reactivity on higher α-olefin. | 11-17-2011 |
| Patent application number | Description | Published |
|---|
| 20100137669 | ETHYLENE TETRAMERIZATION CATALYST SYSTEMS AND METHOD FOR PREPARING 1-OCTENE USING THE SAME - Disclosed herein is a method of preparing 1-octene at high activity and high selectivity while stably maintaining reaction activity by tetramerizing ethylene using a chromium-based catalyst system comprising a transition metal or a transition metal precursor, a cocatalyst, and a P—C—C—P backbone structure ligand represented by (R | 06-03-2010 |
| 20100145124 | ETHEYENE OLIGOMERIZA CATALYST SYSTEMS HAVING ENEHANCED SELECTIVITY - Disclosed herein is a catalyst system for selective oligomerization of ethylene, which comprises a P—C—C—P frame-work ligand, which is (R | 06-10-2010 |
| 20100234545 | ETHYLENE COPOLYMER HAVING MULTIPLE PITCH MOLECULAR WEIGHT DISTRIBUTION AND THE METHOD OF PREPARING THE SAME - Disclosed are an ethylene polymerization process, a catalyst for use in the process, a production method employing the catalyst, and a product produced thereby. More specifically, disclosed is a process of producing an ethylene copolymer from ethylene and an alpha-olefin comonomer, in which the produced ethylene copolymer has a multimodal molecular weight distribution and excellent processability and physical properties, and thus can increase the value and productivity of products, including pipes and films. Particularly, the produced ethylene copolymer has a trimodal or higher molecular weight distribution or density distribution, and thus, when it is a linear low-density copolymer, it has an excellent effect of improving the impact strength of films, and when it is a medium-density ethylene copolymer, it can be produced into pipes, which have slow crack growth rate and can be used even at high temperature. | 09-16-2010 |
| Patent application number | Description | Published |
|---|
| 20090269414 | PROCESS OF PREPARING MICROSPHERES FOR SUSTAINED RELEASE HAVING IMPROVED DISPERSIBILITY AND SYRINGEABILITY - Disclosed is a process of preparing sustained release microspheres, containing a biodegradable polymer as a carrier and a drug, using spray drying. The process comprises preparing a solution, suspension or emulsion containing a biodegradable polymer, a drug and a solvent; spray drying the solution, suspension or emulsion; and suspending spray-dried microspheres in an aqueous solution containing polyvinyl alcohol to remove the residual solvent and increase the hydrophilicity of the microsphere surface. The process enables the preparation of microspheres having high drug encapsulation efficiency, almost not having a toxicity problem due to the residual solvent, and having good syringeability. The microspheres prepared according to the present invention release an effective concentration of a drug in a sustained manner for a predetermined period when administered to the body, and are thus useful in the treatment of diseases. | 10-29-2009 |
| 20100136126 | COMPOSITION AND MICROSPHERE FOR CONTROLLED-RELEASE OF EXENDIN, AND METHOD OF PREPARING THE SAME - A controlled-release composition and controlled-release microspheres containing an exendin as an active ingredient, and a method of preparing the same are provided. More specifically, a controlled-release composition containing an exendin as an active ingredient, a biodegradable polymer with a specific viscosity, and coating materials, having high bioavailability and showing sustained release of the active ingredient in an effective concentration for a certain period without an excessive initial burst of the active ingredient; controlled-release microspheres containing a core including an exendin as an active ingredient and a biodegradable polymer, and a coating layer coating the core; and a method of preparing controlled-release microspheres including the steps of mixing an exendin, a biodegradable polymer, and a solvent, removing the solvent from the mixture to prepare hardened microspheres, and coating the hardened microspheres to form a coating layer on the surface of each microsphere, are provided. | 06-03-2010 |
